Published in Leuk Res on August 04, 2010
Optimizing management of ruxolitinib in patients with myelofibrosis: the need for individualized dosing. J Hematol Oncol (2013) 0.98
Myelofibrosis-associated complications: pathogenesis, clinical manifestations, and effects on outcomes. Int J Gen Med (2014) 0.98
Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies. Haematologica (2013) 0.97
Management of cytopenias in patients with myelofibrosis treated with ruxolitinib and effect of dose modifications on efficacy outcomes. Onco Targets Ther (2013) 0.96
Effects of ruxolitinib treatment on metabolic and nutritional parameters in patients with myelofibrosis from COMFORT-I. Clin Lymphoma Myeloma Leuk (2014) 0.96
JAK2 Allele Burden in the Myeloproliferative Neoplasms: Effects on Phenotype, Prognosis and Change with Treatment. Ther Adv Hematol (2011) 0.95
Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group. Leukemia (2015) 0.93
Novel myelofibrosis treatment strategies: potential partners for combination therapies. Leukemia (2014) 0.81
Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis. Haematologica (2016) 0.80
Ruxolitinib for myelofibrosis--an update of its clinical effects. Clin Lymphoma Myeloma Leuk (2013) 0.79
Emerging drugs for myelofibrosis. Expert Opin Emerg Drugs (2012) 0.77
Ruxolitinib: long-term management of patients with myelofibrosis and future directions in the treatment of myeloproliferative neoplasms. Curr Hematol Malig Rep (2014) 0.77
Efficacy and safety of ruxolitinib in the treatment of patients with myelofibrosis. Future Oncol (2015) 0.77
Critical appraisal of the role of ruxolitinib in myeloproliferative neoplasm-associated myelofibrosis. Onco Targets Ther (2015) 0.76
Ruxolitinib is effective in patients with intermediate-1 risk myelofibrosis: a summary of recent evidence. Leuk Lymphoma (2016) 0.75
Treatment and management of myelofibrosis in the era of JAK inhibitors. Biologics (2013) 0.75
Managing Patients With Myelofibrosis in the Era of Janus Kinase Inhibitors. J Adv Pract Oncol (2015) 0.75
Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis. J Hematol Oncol (2017) 0.75
Which clinical significance has automatic detection of very low levels of nucleated red blood cells in the peripheral blood? Ann Transl Med (2016) 0.75
A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence. Leukemia (2016) 0.75
Allogeneic stem cell transplant for myelofibrosis patients over age 60: likely impact of the JAK2 inhibitors. Leuk Suppl (2012) 0.75
World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol (1999) 12.42
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature (1985) 8.32
Graft-versus-leukemia reactions after bone marrow transplantation. Blood (1990) 7.11
Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature (1998) 5.59
IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol (1997) 4.52
Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell (1986) 3.59
Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst (1989) 3.48
Bone marrow transplantation after the Chernobyl nuclear accident. N Engl J Med (1989) 3.46
Cord-blood-cell transplantation--a real sleeper? N Engl J Med (1995) 3.29
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol (1990) 3.19
Mutations and prognosis in primary myelofibrosis. Leukemia (2013) 3.13
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood (2001) 2.99
Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med (1987) 2.98
Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood (1994) 2.93
Gestational diabetes mellitus in India. J Assoc Physicians India (2004) 2.86
Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia (2012) 2.85
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol (1997) 2.79
Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms. Ann Oncol (2000) 2.66
Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate. Leukemia (2006) 2.66
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. Leukemia (2003) 2.60
Expression of T cell antigen receptor heterodimers in a lipid-linked form. Science (1990) 2.56
Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. Arch Intern Med (1983) 2.53
HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry. Ann Intern Med (1996) 2.52
The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology (2000) 2.51
Familiarity with and social distance from people who have serious mental illness. Psychiatr Serv (2001) 2.47
Buteyko breathing techniques in asthma: a blinded randomised controlled trial. Med J Aust (1999) 2.42
Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. BMJ (1995) 2.40
The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997. Hematol J (2000) 2.34
Clinical uses of intravenous immunoglobulins. Ann Intern Med (1990) 2.29
Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood (1976) 2.29
Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med (2001) 2.26
T-cell depletion of HLA-identical transplants in leukemia. Blood (1991) 2.25
Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Health Technol Assess (1997) 2.20
Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med (1999) 2.19
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology (2006) 2.19
Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab (1999) 2.13
N-acetylcysteine replenishes glutathione in HIV infection. Eur J Clin Invest (2000) 2.13
Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. Proc Natl Acad Sci U S A (1993) 2.12
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood (1993) 2.12
Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia. Ann Intern Med (1980) 2.11
The importance of genes and environment for ocular refraction and its determiners: a population based study among 20-45 year old twins. Br J Ophthalmol (2001) 2.09
Is there a T-cell form of chronic lymphocytic leukemia? Leukemia (1992) 2.08
The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab (1995) 2.07
Cause of death and correlation with autopsy findings in burns patients. Burns (2012) 2.07
Epidemiological studies of diabetes mellitus in Denmark. II. A prevalence study based on insulin prescriptions. Diabetologia (1981) 2.06
Tolerance of nicotinamide and carbogen with radiation therapy for glioblastoma. Radiother Oncol (1996) 2.03
Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type. Bone Marrow Transplant (2009) 2.03
Health sector reform and the interpretation of policy context. Health Policy (1999) 2.00
Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med Scand (1980) 1.98
What's new in blood progenitor cell autotransplants? Bone Marrow Transplant (1994) 1.98
Further evidence for an association between genetic variation in transforming growth factor alpha and cleft lip and palate. Am J Hum Genet (1991) 1.98
Polymorphonuclear leukocytes in antibody-dependent cellular cytotoxicity. J Immunol (1975) 1.98
Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood (1990) 1.98
Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut (2002) 1.96
Prejudice, social distance, and familiarity with mental illness. Schizophr Bull (2001) 1.95
Nail patella syndrome: a review of the phenotype aided by developmental biology. J Med Genet (2003) 1.95
Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. Cancer Res (1993) 1.89
How much residual plasma may cause TRALI? Transfus Med (2008) 1.85
A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood (1979) 1.83
Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS. Bone Marrow Transplant (2011) 1.82
Beyond ovulation: oral contraceptives and epithelial ovarian cancer. Epidemiology (2000) 1.82
Review of the epidemiologic literature on EMF and Health. Environ Health Perspect (2001) 1.80
Risk analysis in the development of pterygia. Ophthalmology (1992) 1.79
A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosis. Leukemia (2008) 1.79
High remission-induction rate in acute myeloid leukaemia. Lancet (1977) 1.78
Idiopathic adhesive capsulitis. A prospective functional outcome study of nonoperative treatment. J Bone Joint Surg Am (2000) 1.78
Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers? Blood (1992) 1.77
Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders. Leukemia (2008) 1.77
Common acquired naevi and the risk of malignant melanoma. Int J Cancer (1985) 1.76
The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation (1996) 1.75
Decentralization and primary health care: some negative implications in developing countries. Int J Health Serv (1994) 1.75
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J Clin Oncol (1997) 1.75
Infectious complications of human bone marrow transplantation. Medicine (Baltimore) (1979) 1.74
Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes. Ann Intern Med (1982) 1.74
Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann Intern Med (1988) 1.73
Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology. Br J Haematol (1995) 1.70
Outcome after allogeneic bone marrow transplant for leukemia in older adults. JAMA (1993) 1.70
Surface markers on leukemia and lymphoma cells: recent advances. Blood (1982) 1.69
Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE). Int J Cancer (1995) 1.68
The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol (2000) 1.68
Melanocytic lesions excised from the skin: what percentage are malignant? Aust J Public Health (1994) 1.67
Identification of non-heme diiron proteins that catalyze triple bond and epoxy group formation. Science (1998) 1.67
Biopterin derivatives in normal and phenylketonuric patients after oral loads of L-phenylalanine, L-tyrosine, and L-tryptophan. Arch Dis Child (1976) 1.66
Prevalence of K329E mutation in medium-chain acyl-CoA dehydrogenase gene determined from Guthrie cards. Lancet (1991) 1.66
Is childhood-onset type I diabetes a wealth-related disease? An ecological analysis of European incidence rates. Diabetologia (2001) 1.66
Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis. Br J Cancer (2007) 1.66
Chronic graft versus host disease: a syndrome of disordered immunity. Am J Med (1979) 1.65
Acute lymphoblastic leukemia: recent advances in biology and therapy. Blood (1989) 1.65
Age of onset and type of leukaemia. Lancet (1989) 1.64
Studies of the HLA system and insulin-dependent diabetes mellitus. Diabetes Care (1980) 1.63
Agonist control of G-protein levels. Trends Pharmacol Sci (1991) 1.63
Comparative pupil dilation using phenylephrine alone or in combination with tropicamide. Ophthalmology (1998) 1.61
A study of patient satisfaction and adherence to preventive care practice guidelines. Am J Med (1995) 1.60